Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schofield

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2022
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brainsBrenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodiesOhan Mazigi, David B Langley, Jake Y Henry, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Nature Communications|February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsRomain Rouet, Jake Y Henry, Matt D Johansen, et al.
Frontiers in Immunology|December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cellsChansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)Andrew J Aschenbrenner, Bryan D James, Eric McDade, et al.
International Journal of Mental Health Systems|May 2, 2026
Towards a new model of population mental health research and policy translation in the UK: establishing a National consortiumTassia Kate Oswald, Joseph Barker, Daniel Barrett, et al.
Research Square|August 7, 2024
Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's DiseaseEric McDade, Haiyan Liu, Quoc Bui, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2022
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brainsBrenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodiesOhan Mazigi, David B Langley, Jake Y Henry, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Nature Communications|February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsRomain Rouet, Jake Y Henry, Matt D Johansen, et al.
Frontiers in Immunology|December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cellsChansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)Andrew J Aschenbrenner, Bryan D James, Eric McDade, et al.
International Journal of Mental Health Systems|May 2, 2026
Towards a new model of population mental health research and policy translation in the UK: establishing a National consortiumTassia Kate Oswald, Joseph Barker, Daniel Barrett, et al.
Research Square|August 7, 2024
Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's DiseaseEric McDade, Haiyan Liu, Quoc Bui, et al.
Pageof 18